Nitric Oxide During Bypass for Arterial Switch Operation

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.

Also called NCT03661385

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 300 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03661385
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Australia, Canada, Indonesia, Malaysia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03661385. Randomized; quadruple masking; primary purpose prevention. Start 2018-07-11 (actual); primary completion 2022-03-23 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Nitric Oxide During Bypass for Arterial Switch Operation
Acronym
NASO
Condition
Low Cardiac Output Syndrome
Condition
Transposition of Great Vessels
Intervention (Drug)
Nitric Oxide
Lead sponsor
Murdoch Childrens Research Institute (class: other)

Record details

Record id
cardio:ct-nct03661385
Content hash
a380e12dbc46f91e5be3121996fe28fe405d0b199dd0e2a76559069920cfc6fa